Understand the source comparison
Ipamorelin Beginners Guide: Comparison Table
Before selecting a growth hormone secretagogue for research applications, understanding the selectivity, receptor interactions, and off-target effects is essential. This table compares ipamorelin against other commonly used peptides in GH research protocols. |
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a growth hormone secretagogue for research applications, understanding the selectivity, receptor interactions, and off-target effects is essential. This table compares ipamorelin against other commonly used peptides in GH research protocols.
- | Peptide | Receptor Selectivity | GH Pulse Amplitude | Cortisol/Prolactin Effect | Half-Life (Plasma) | Primary Research Applications | Bottom Line ||—|—|—|—|—|—|| Ipamorelin | High (GHS-R1a selective, minimal off-target binding) | 2.5–3.2× baseline | Minimal (<10% elevation) | 2–3 hours | Isolated GH pathway studies, circadian research, metabolic signaling without confounding stress hormones | Best choice for clean GH pathway isolation with minimal endocrine interference || GHRP-2 | Moderate (GHS-R1a primary, some GHS-R1b cross-reactivity) | 3.5–4.0× baseline | Moderate (40–60% cortisol increase) | 20–30 minutes | Studies requiring maximal GH output, appetite regulation research, stress hormone interaction models | Higher GH output but cortisol elevation confounds metabolic endpoints || GHRP-6 | Low (broad ghrelin receptor activation) | 3.0–3.5× baseline | High (60–80% cortisol increase, significant appetite stimulation) | 15–20 minutes | Appetite and feeding behavior research, ghrel
- Ipamorelin's combination of high selectivity, moderate amplitude, and minimal cortisol effect makes it the most versatile secretagogue for research requiring clean GH pathway activation. Researchers studying acute GH effects without endocrine confounders consistently choose ipamorelin, while those examining appetite, stress hormone interactions, or cardiovascular effects select peptides with broader receptor profiles.